Cargando…

Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers

The epidemiology of candidemia varies geographically, and there is still scarce data on the epidemiology of candidemia in Latin America (LA). After extensive revision of medical literature, we found reliable and robust information on the microbiological aspects of candidemia in patients from 11 out...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Matta, Daniel Archimedes, Souza, Ana Carolina Remondi, Colombo, Arnaldo Lopes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715916/ https://www.ncbi.nlm.nih.gov/pubmed/29371542 http://dx.doi.org/10.3390/jof3020024

Ejemplares similares

Short Tandem Repeat Genotyping and Antifungal Susceptibility Testing of Latin American Candida tropicalis Isolates
por: Spruijtenburg, Bram, et al.
Publicado: (2023)

Pathogenesis of the Candida parapsilosis Complex in the Model Host Caenorhabditis elegans
por: Souza, Ana Carolina Remondi, et al.
Publicado: (2018)

Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea
por: Lee, Jin-Sol, et al.
Publicado: (2007)

Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
por: Pinhati, Henrique Marconi Sampaio, et al.
Publicado: (2016)

Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong
por: Seneviratne, Chaminda J., et al.
Publicado: (2016)

Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey
por: Dagi, Hatice Turk, et al.
Publicado: (2016)

146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
por: Tesini, Brenda L, et al.
Publicado: (2020)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital
por: Marins, Tatiana Aporta, et al.
Publicado: (2018)

Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
por: Rezazadeh, Elham, et al.
Publicado: (2016)

Invasive Candida parapsilosis Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes
por: Wang, Yao-Sheng, et al.
Publicado: (2023)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
por: Costa-de-Oliveira, Sofia, et al.
Publicado: (2020)

Emergence of cryptic species and clades of Meyerozyma guilliermondii species complex exhibiting limited in vitro susceptibility to antifungals in patients with candidemia
por: Francisco, Elaine Cristina, et al.
Publicado: (2023)

Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China
por: Wang, Feng-Juan, et al.
Publicado: (2016)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
por: González-Lara, María Fernanda, et al.
Publicado: (2017)

277. Identification and Antifungal Susceptibility of Candida Species Isolated from Bloodstream Infections Over a 14-Year Period
por: Kline, Ahnika, et al.
Publicado: (2019)

A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey
por: Yang, Beibei, et al.
Publicado: (2023)

Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen
por: Dal Mas, Caroline, et al.
Publicado: (2019)

Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
por: Dalyan Cilo, Burcu
Publicado: (2023)

Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group
por: Firacative, Carolina, et al.
Publicado: (2021)

The emerging threat antifungal-resistant Candida tropicalis in humans, animals, and environment
por: Lima, Ricardo, et al.
Publicado: (2022)

Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
por: Villegas, Maria Virginia, et al.
Publicado: (2016)

Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital
por: Alkharashi, Nawaf, et al.
Publicado: (2019)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait
por: Khan, Ziauddin, et al.
Publicado: (2019)

A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes
por: Rodriguez, Lourdes, et al.
Publicado: (2017)

Antifungal susceptibility testing of Candida species by flow cytometry.
por: Lee, W., et al.
Publicado: (1999)

Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015)

Molecular Typing and Antifungal Susceptibility of Candida viswanathii, India
por: Shankarnarayan, Shamanth A., et al.
Publicado: (2018)

Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry
por: Di Luca, Mariagrazia, et al.
Publicado: (2019)

Correction to: P-42 Distribution and antifungal susceptibility of Candida isolates in a Tunisian burn unit
por: Sonia, Trabelsi, et al.
Publicado: (2019)

Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis
por: Bilal, Hazrat, et al.
Publicado: (2022)

Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China
por: Qiao, Yan, et al.
Publicado: (2023)

In Vitro Antifungal Activity of Manogepix and Other Antifungal Agents against South African Candida auris Isolates from Bloodstream Infections
por: Maphanga, Tsidiso G., et al.
Publicado: (2022)

Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts
por: Hou, Xin, et al.
Publicado: (2017)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis
por: Gharehbolagh, Sanaz Aghaei, et al.
Publicado: (2020)

Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran
por: LOTFALI, Ensieh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ovafrsqrob0m754n97op67sphi